C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/72 (2006.01) A61K 38/49 (2006.01)
Patent
CA 2537696
The invention relates to the use of plasminogen activators having reduced lysine binding capacity in the treatment of thrombotic disorders.
L'invention concerne l'utilisation d'activateurs plasminogènes à capacité de liaison lysine réduite pour traiter une maladie thrombotique.
Ellis Vincent
Kops Oliver
Schubart Daniel
Schultz Torsten
Sohngen Wolfgang
Norton Rose Or S.e.n.c.r.l.,s.r.l./llp
Paion Deutschland Gmbh
LandOfFree
Plasminogen activators having a reduced capacity to bind lysine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasminogen activators having a reduced capacity to bind lysine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasminogen activators having a reduced capacity to bind lysine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1936606